Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Noncompact myelin-associated protein (NCMAP) is a glycosylated protein predominantly expressed in the peripheral nervous system, where it functions as a structural constituent of the myelin sheath. It is essential for the formation, stability, and maintenance of myelin, especially in the peripheral nervous system, and is particularly localized to noncompact regions of myelin such as the Schmidt-Lanterman incisures and paranodal regions of axons. NCMAP is not recognized as a classic drug target, receptor, or enzyme, but mutations and differential expression have been associated with certain neurological syndromes[1][2][3][6][7][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Noncompact myelin-associated protein (NCMAP).